Patents by Inventor Dennis Ladage

Dennis Ladage has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SERCA2 THERAPEUTIC COMPOSITIONS AND METHODS OF USE
    Publication number: 20180099029
    Abstract: The present invention provides methods for treating pulmonary hypertension in a subject by delivering a therapeutic adeno-associated virus (AAV)-SERCA2 composition to a subject in need thereof.
    Type: Application
    Filed: June 27, 2013
    Publication date: April 12, 2018
    Applicants: Mount Sinai School of Medicine, Celladon Corporation
    Inventors: Roger J. Hajjar, Yoshiaki Kawase, Dennis Ladage, Krisztina Zsebo
  • SERCA2 THERAPEUTIC COMPOSITIONS AND METHODS OF USE
    Publication number: 20170065685
    Abstract: The present invention provides methods for treating pulmonary hypertension in a subject by delivering a therapeutic adeno-associated virus (AAV)-SERCA2 composition to a subject in need thereof.
    Type: Application
    Filed: November 21, 2016
    Publication date: March 9, 2017
    Inventors: Roger J. Hajjar, Yoshiaki Kawase, Dennis Ladage, Krisztina Zsebo
  • SERCA2 THERAPEUTIC COMPOSITIONS AND METHODS OF USE
    Publication number: 20130287739
    Abstract: The present invention provides methods for treating pulmonary hypertension in a subject by delivering a therapeutic adeno-associated virus (AAV)-SERCA2 composition to a subject in need thereof.
    Type: Application
    Filed: June 27, 2013
    Publication date: October 31, 2013
    Applicants: Mount Sinai School of Medicine, Celladon Corporation
    Inventors: Roger J. Hajjar, Yoshlaki Kawase, Dennis Ladage, Krisztina Zsebo
  • SERCA2 THERAPEUTIC COMPOSITIONS AND METHODS OF USE
    Publication number: 20110256101
    Abstract: The present invention provides methods for treating pulmonary hypertension in a subject by delivering a therapeutic adeno-associated virus (AAV)-SERCA2 composition to a subject in need thereof.
    Type: Application
    Filed: April 14, 2011
    Publication date: October 20, 2011
    Applicants: Mount Sinai School of Medicine, Celladon Corporation
    Inventors: Roger J. Hajjar, Yoshiaki Kawase, Dennis Ladage, Krisztina Zsebo